Fundz

Altimmune Appoints Linda M. Richardson as Chief Commercial Officer

PUBLIC · ALTSep 15, 2025

Position

Chief Commercial Officer

Company

Altimmune

Linda M. Richardson
lrichardson@altimmune.com
GaithersburgBiotechnologyHealth CareTherapeuticsBiopharmaresearch

Description

Altimmune, Inc has announced the appointment of Linda M Richardson as Chief Commercial Officer, effective September 16, 2025. With over 30 years of experience, she is set to lead the company’s commercial readiness initiatives.

Company Information

Company

Altimmune

Location

910 Clopper Rd

Gaithersburg, Maryland, United States

About

Altimmune is a late clinical-stage biopharmaceutical company focused on developing novel peptide-based therapeutics for liver and cardiometabolic diseases. The Company’s lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist for the treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH), Alcohol Use Disorder (AUD), Alcohol-associated Liver Disease (ALD) and obesity.

Fundz sees it the moment Altimmune changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Karen
Likely contact at this company
••••••••@••••••••

See Karen's verified email →

Siavoche
Likely contact at this company
••••••••@••••••••

See Siavoche's verified email →

Sarah
Likely contact at this company
••••••••@••••••••

See Sarah's verified email →

Greg
Likely contact at this company
••••••••@••••••••

See Greg's verified email →

Richard
Likely contact at this company
••••••••@••••••••

See Richard's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Altimmune's next move

Learn about Strategic plan

Altimmune changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.